Deacom's AutoFinisher automates serialized and catch weight production
New AutoFinisher moves manufacturing jobs from scale to label in under one second.
Deacom has launched its new AutoFinisher tool as part of its core ERP solution. Now process manufacturers of serialized or catch-weight products can efficiently weigh, serialize, label, palletize and report on production all within one, cohesive platform. Achieving this level of automation is particularly valuable for food and pharmaceutical industries where serialized and catch weight production adds complexity to the manufacturing process.
"There is a big push towards manufacturing automation and we believe that ERP solutions should play a key role in influencing this movement," said Scott Deakins, COO of Deacom. "By developing such capabilities that are native to our single-system ERP software, like the AutoFinisher, we are able to help support our customers in this progression. In fact, Deacom customers who are already using this feature have experienced drastic improvements in production efficiencies and results. This enhancement is just one example of Deacom's dedication towards the continuous product advancements designed to further enable the scalability of manufacturing companies."
Deacom's single-system ERP architecture allows the AutoFinisher to access and generate real-time data in the ERP platform. This is in sharp contrast to traditional ERP systems, which rely on heavy customizations and bolt-ons to support an entire business, including AutoFinisher-like capabilities. As more modules and customizations are implemented, the level of complexity begins to restrict business growth.
By building the AutoFinisher directly into the core Deacom ERP software, the benefits to customers are significant:
For companies in the pharmaceutical industry where production lines run well over 100 units per minute, sustaining this rate while adhering to new regulatory demands is of great concern. The Deacom AutoFinisher is able to generate serial number information and print relevant labels at unit, case, and pallet levels without affecting production speed.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.